Full-Time

Associate Director

Accounting

Updated on 5/2/2024

Coherus BioSciences

Coherus BioSciences

201-500 employees

Develops next-generation immuno-oncology therapies

Biotechnology

Senior

San Carlos, CA, USA

Requirements
  • Bachelor's degree in finance, accounting or related field
  • Minimum of 8 years of increasing responsibility in accounting or finance
  • Comprehensive expertise in accounting operations and internal controls with knowledge of US GAAP
  • Exceptional verbal communication skills and the writing ability to produce polished final drafts without help
  • Experience working in a publicly traded company owning SOX processes
  • Track record of thriving in fast-paced environments
  • Self-motivated, detail-oriented and highly organized
  • Excellent Excel spreadsheet skills
  • Experience in a commercial-stage pharmaceutical/biopharmaceutical
  • CPA or CMA
  • Formal training in process improvement
Responsibilities
  • Maintain a process-driven, high-performing Operational Accounting team
  • Lead, mentor and develop accounting team in a way that is effective and makes everyone want to work here
  • Manage relationship with external auditors and oversee the annual audit and quarterly review process
  • Manage timely and accurate preparation of monthly, quarterly, and annual financial results
  • Support external financial reporting function, including statutory reporting (10-Q, 10-K, Proxy, etc) as needed
  • Be a strong partner to FP&A, Tax advisors and Commercial teams and provide analyses that are thorough and insightful
  • Drive cyber and process vigilance and other deterrence against bad actors

With an emphasis on immuno-oncology and cutting-edge therapies, this company stands out in the biotechnology industry for its dedicated approach to cancer treatment and improving patient outcomes. The development and FDA-approval of cutting-edge treatments like toripalimab-tpzi underscore its role as a leader in oncology research. Its focus on next-generation therapies and a differentiated PD-1 inhibitor highlights the company's commitment to both innovation and tangible results in healthcare.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

-6%

1 year growth

-6%

2 year growth

-6%

Benefits

Competitive base salary

Target bonus based on performance

stock options

Medical, dental, & vision coverage

PTO

401(k) plan

FSA